Patents & Intellectual Property

Ardea Biosciences owns a total of two issued United States patents, 16 pending United States non-provisional patent applications, seven pending United States provisional patent applications, eight pending international patent applications and 80 pending foreign patent applications (as of March 2009). All of our patent applications were filed after June 8, 1995.

Patents

	USPTO, 10/14/08
	Np[S(4-ARYL-TRIAZOL-3-YL)α-MER CAPTOACETYL]-P-AMINO BENOZIOC ACIDS AS HIV REVERSE TRANSCRIPTASE INHIBITORS
	Jean-Luc Girardet, et. al.